With a Expansion round Deepc closes its Series A with a €12 million ($13 million) round. Sofinnova Partners and Bertelsmann Investments led the financing round. In addition to existing investor Winning Mindset Ventures, new investors also participated. KHP Ventures and Swiss Health VenturesThe fresh capital is used by Startupto accelerate its growth and international expansion and improve its operating system. Key growth priorities include expanding its presence in the United States, expanding into the United Kingdom, and doubling its exposure to key European markets.
Franz Pfister, CEO and co-founder of Deepc, explains:
"At Deepc, we believe that the potential of AI in healthcare can only be realized if we can bridge the gap between cutting-edge AI and clinical practice. Our platform makes it easy for organizations to deploy the best AI technologies quickly and at scale to enable faster and more accurate diagnoses and ultimately improve patient outcomes. We are delighted to welcome Swiss Health Ventures and KHP Ventures alongside our existing investors Sofinnova Partners, Bertelsmann Investments, and Winning Mindset Ventures. Together, they bring tremendous strategic value to Deepc and will be a great asset as we continue to scale internationally and invest further in our platform."
DeepOS's operating system supports the daily work of radiologists. The company's platform solution provides medical professionals with access to AI solutions for radiology, enabling more accurate diagnoses and treatment decisions. According to the company, DeepOS is already in use at numerous renowned institutions. These include the Solothurn Hospital in Switzerland, the Vivantes Clinic Group and the LMU University Hospital in Germany, and the National Health Service in England.
Simon Turner, Partner at Sofinnova Partners, says:
"The influx of capital into AI underscores the importance of enabling technologies that drive adoption in healthcare. These enabling technologies are at the heart of Sofinnova's digital medicine strategy and are an area that few have mastered so far. From the outset, we recognized Deepc's potential to revolutionize the use of AI in healthcare. This conviction is now strengthened by the support of our new investors, who bring a wealth of expertise to further accelerate the company's growth.
